A phase I study of adenovirus mediated gene transfer of interleukin 2 cDNA into metastatic breast cancer or melanoma

被引:19
作者
Stewart, AK
Lassam, NJ
Graham, FL
Gauldie, J
Addison, CL
Bailey, DJ
Dessureault, S
Dube, ID
Gallenger, S
Krajden, M
Rotstein, LE
Quirt, IC
Moen, R
机构
[1] UNIV TORONTO,DEPT PATHOL,TORONTO,ON,CANADA
[2] UNIV TORONTO,DEPT SURG,TORONTO,ON,CANADA
[3] TORONTO HOSP,DIV HEMATOL ONCOL,TORONTO,ON M5T 2S8,CANADA
[4] SUNNYBROOK HLTH SCI CTR,DEPT LAB MED,TORONTO,ON M4N 3M5,CANADA
[5] TORONTO HOSP,CLIN VIROL LAB,TORONTO,ON M5T 2S8,CANADA
[6] MCMASTER UNIV,SCH MED,DEPT PATHOL,HAMILTON,ON L8S 4L8,CANADA
[7] MCMASTER UNIV,SCH MED,DEPT BIOL,HAMILTON,ON L8S 4L8,CANADA
关键词
D O I
10.1089/hum.1997.8.11-1403
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
[No abstract available]
引用
收藏
页码:1403 / 1414
页数:12
相关论文
共 60 条
[41]   INTEGRATION AND EXPRESSION OF VIRAL-DNA IN CELLS TRANSFORMED BY HOST RANGE MUTANTS OF ADENOVIRUS TYPE-5 [J].
RUBEN, M ;
BACCHETTI, S ;
GRAHAM, FL .
JOURNAL OF VIROLOGY, 1982, 41 (02) :674-685
[42]   INTERLEUKIN-2 TOXICITY [J].
SIEGEL, JP ;
PURI, RK .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) :694-704
[43]   ADENOVIRUS-MEDIATED TRANSFER OF THE CFTR GENE TO LUNG OF NONHUMAN-PRIMATES - TOXICITY STUDY [J].
SIMON, RH ;
ENGELHARDT, JF ;
YANG, YP ;
ZEPEDA, M ;
WEBERPENDLETON, S ;
GROSSMAN, M ;
WILSON, JM .
HUMAN GENE THERAPY, 1993, 4 (06) :771-780
[44]  
SMITH RR, 1956, CANCER, V9, P1211, DOI 10.1002/1097-0142(195611/12)9:6<1211::AID-CNCR2820090624>3.0.CO
[45]  
2-7
[46]  
STRATFORDPERRIC.L, 1991, HUMAN GENE TRANSFER, V219, P51
[47]   ANALYSIS OF CYTOLYTIC EFFECTOR CELL RESPONSE INVITRO AGAINST AUTOLOGOUS HUMAN TUMOR-CELLS GENETICALLY ALTERED TO SYNTHESIZE INTERLEUKIN-2 [J].
TOHMATSU, A ;
OKINO, T ;
STABACH, P ;
PADULA, SJ ;
ERGIN, MT ;
MUKHERJI, B .
IMMUNOLOGY LETTERS, 1993, 35 (01) :51-58
[48]   CONTROL OF RESPIRATORY DISEASE IN RECRUITS WITH TYPES-4 AND 7 ADENOVIRUS VACCINES [J].
TOP, FH ;
DUDDING, BA ;
RUSSELL, PK ;
BUESCHER, EL .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1971, 94 (02) :142-&
[49]  
TOPALIAN SL, 1989, J IMMUNOL, V142, P3714
[50]  
TOPALIAN SL, 1990, J IMMUNOL, V144, P4487